合成弛豫测量预测早产儿神经发育结局的诊断性能:可行性研究
本回顾性研究纳入33例近足月或足月等效年龄时接受合成MRI扫描的早产儿,按矫正年龄18-24个月神经发育评估分为无/轻度残疾组23例与中/重度残疾组10例。结果显示,T1-额叶/顶叶及T2-顶叶脑室周围白质弛豫时间延长、中重度白质异常及支气管肺发育不良与中/重度残疾显著相关;临床变量联合T1-顶叶脑室周围白质模型的AUC为0.94、敏感度90%、特异度91.3%,优于单纯临床模型(P=0.049)。
要点
- T1-顶叶脑室周围白质弛豫时间预测不良结局AUC为0.76、准确率78.8%。
- 临床变量联合T1-顶叶脑室周围白质模型AUC 0.94、敏感度90%、特异度91.3%。
- MRI表现联合T1-额叶脑室周围白质模型AUC 0.86,仅边缘优于MRI表现模型(P=0.09)。
核心结论
- 利用新生儿期合成弛豫测量预测早产儿不良神经发育结局是可行的,弛豫时间联合临床变量或MRI表现可提高预测性能。
研究设计与样本
- 回顾性研究,纳入33例在近足月或足月等效年龄接受合成MRI扫描的早产儿,以矫正年龄18-24个月神经发育评估为参考标准,采用bootstrap重采样进行内部验证。
关键影像表现/征象
- T1-额叶/顶叶及T2-顶叶脑室周围白质弛豫时间延长与中/重度残疾显著相关。
- 中重度白质异常与中/重度残疾显著相关。
- 支气管肺发育不良与中/重度残疾显著相关。
诊断标准与关键数值
- T1-额叶脑室周围白质模型预测中/重度残疾的AUC为0.71。
- T1-顶叶脑室周围白质模型预测中/重度残疾的AUC为0.76、准确率78.8%。
- MRI表现模型预测中/重度残疾的AUC为0.73。
- 临床变量模型预测中/重度残疾的AUC为0.83。
- 临床变量联合T1-顶叶脑室周围白质模型预测中/重度残疾的AUC为0.94、敏感度90%、特异度91.3%,优于单纯临床模型(P=0.049)。
临床应用与阅片要点
- 新生儿期合成MRI弛豫测量可能作为预测早产儿不良神经发育结局的生物标志物。
- 将弛豫时间与临床变量和/或结构MRI异常联合可提高对不良结局的预测性能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the predictability of synthetic relaxometry for neurodevelopmental outcomes in premature infants and to evaluate whether a combination of relaxation times with clinical variables or qualitative MRI abnormalities improves the predictive performance.
METHODS: This retrospective study included 33 premature infants scanned with synthetic MRI near or at term equivalent age. Based on neurodevelopmental assessments at 18-24 months of corrected age, infants were classified into two groups (no/mild disability [n = 23] vs. moderate/severe disability [n = 10]). Clinical and MRI characteristics associated with moderate/severe disability were explored, and combined models incorporating independent predictors were established. Ultimately, the predictability of relaxation times, clinical variables, MRI findings, and a combination of the two were evaluated and compared. The models were internally validated using bootstrap resampling.
RESULTS: Prolonged T1-frontal/parietal and T2-parietal periventricular white matter (PVWM), moderate-to-severe white matter abnormality, and bronchopulmonary dysplasia were significantly associated with moderate/severe disability. The overall predictive performance of each T1-frontal/-parietal PVWM model was comparable to that of individual MRI finding and clinical models (AUC = 0.71 and 0.76 vs. 0.73 vs. 0.83, respectively; p > 0.27). The combination of clinical variables and T1-parietal PVWM achieved an AUC of 0.94, sensitivity of 90%, and specificity of 91.3%, outperforming the clinical model alone (p = 0.049). The combination of MRI finding and T1-frontal PVWM yielded AUC of 0.86, marginally outperforming the MRI finding model (p = 0.09). Bootstrap resampling showed that the models were valid.
CONCLUSIONS: It is feasible to predict adverse outcomes in premature infants by using early synthetic relaxometry. Combining relaxation time with clinical variables or MRI finding improved prediction.
CLINICAL RELEVANCE STATEMENT: Synthetic relaxometry performed during the neonatal period may serve as a biomarker for predicting adverse neurodevelopmental outcomes in premature infants.
KEY POINTS: • Synthetic relaxometry based on T1 relaxation time of parietal periventricular white matter showed acceptable performance in predicting adverse outcome with an AUC of 0.76 and an accuracy of 78.8%. • The combination of relaxation time with clinical variables and/or structural MRI abnormalities improved predictive performance of adverse outcomes. • Synthetic relaxometry performed during the neonatal period helps predict adverse neurodevelopmental outcome in premature infants.
引用
- Kim JS, Cho HH, Shin JY, et al. Diagnostic performance of synthetic relaxometry for predicting neurodevelopmental outcomes in premature infants: a feasibility study. Eur Radiol. 2023. PMID: 37522898. doi:10.1007/s00330-023-09881-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。